Serum Lactate in Acute Mesenteric Ischemia
Lactate Dehydrogenase, Bowel Necrosis and Mortality in Acute Mesenteric Ischemia: Retrospective Cross-Sectional
1 other identifier
observational
74
1 country
1
Brief Summary
Background: Acute mesenteric ischemia is a vascular emergency with high mortality because of ambiguous symptomatology and a lack of early diagnostic markers. Lactate dehydrogenase has been described as a mortality biomarker and bowel necrosis length too. Nevertheless, the association between them has been mildly studied. Our objective was to evaluate the association between serum lactate admission levels, bowel necrosis extension, and mortality. Additionally, we performed a mortality characterization. Materials and Methods: A retrospective cross-sectional study was designed. We reviewed patients' clinical records with acute mesenteric ischemia that attended a hospital between 2012 and 2018. We compared serum lactate admission levels with bowel necrosis length and mortality. A receiver operating characteristic curve was performed on the last association. As post hoc analysis, a classification and regression tree on mortality was fitted.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started May 2017
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 2, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
June 30, 2020
CompletedFirst Submitted
Initial submission to the registry
December 3, 2020
CompletedFirst Posted
Study publicly available on registry
December 17, 2020
CompletedDecember 17, 2020
December 1, 2020
3.2 years
December 3, 2020
December 11, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Serum Lactate in mmol/l
30 days
Bowel necrosis length in cm
30 days
Percentage of patients that died between 30 postsurgical days, %
30 days
Secondary Outcomes (1)
Cut value of lactate levels as a predictor of mortality, in mmol/l
30 days
Interventions
All the patients that arrived at the hospital with symptoms of mesenteric ischemia, had a registered lactate dehydrogenase. We compared the value with the patient's outcomes.
Eligibility Criteria
Seventy-four cases were identified that met the study's criteria. The patients' average age was 73.5 (SD, 10.7) years, and 44 (60%) were men. The mean body mass index was 25 (SD, 2.9) kg/m2. Fifteen (20%) of the patients presented non-occlusive acute mesenteric ischemia.
You may qualify if:
- Older than 18 years of age
- Required urgent laparotomy with a postoperative diagnosis of acute mesenteric ischemia
- Attended the private academic hospital, between 2012 and 2018
- Had a registered serum lactate dehydrogenase at admission
You may not qualify if:
- Secondary causes of AMI
- Chronic intestinal ischemic
- Patient records with no description of the serum lactate dehydrogenase or extension of intestinal necrosis
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Andres Isaza Restrepo
Bogotá, Cundinamarca, 111221, Colombia
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- CROSS SECTIONAL
- Target Duration
- 30 Days
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MD, MSc
Study Record Dates
First Submitted
December 3, 2020
First Posted
December 17, 2020
Study Start
May 2, 2017
Primary Completion
June 30, 2020
Study Completion
June 30, 2020
Last Updated
December 17, 2020
Record last verified: 2020-12
Data Sharing
- IPD Sharing
- Will not share
We don't plan to share de IPD.